NCT00822081 - Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination

1 drop BID in each eye

DRUG

dorzolamide hcl 2%/ timolol maleate 0.5% fixed combination

1 drop BID in each eye

DRUG

brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy.

1 drop BID in each eye

DRUG

dorzolamide hcl 2%/timolol maleate 0.5% fixed combinatin as adjunctive to current prostaglandin therapy.

1 drop BID in each eye

Trial Locations (1)

Barrie